Pharma Pulse 6/14/24: GLP-1 Drugs Changed the Paradigm in Weight Loss, What’s Coming to Apple Devices & more

Guiding Principles for Trial Participant Communication

Nine tips to help sites close the information and understanding gaps in their dealings with patients.

GLP-1 Drugs Changed the Paradigm in Weight Loss

In an interview, Timothy Law, DO, MBA, chief medical officer of Highmark, talks about how GLP-1 agonist drugs like Wegovy and Zepbound are changing the paradigm for weight loss.

Operational Oversight in Clinical Research: Integrations and Insights

Learn how IQVIA’s CDAS technology and services can provide an efficient path to consolidating and harmonizing data across any provider source, ensuring high quality oversight of outsourced clinical trial activities.

Password App, iPad Calculator, Scheduled Text Messages: What’s Coming Soon to Your Apple Devices

Apple talked a big AI game for iOS 18, iPadOS 18 and MacOS Sequoia, but 10 other tools are also on our fall update radar.

Brightside Health Expands into Substance Use Disorder, Virtual Intensive Outpatient Treatment

In line with its commitment to providing the highest quality care, Brightside Health now offers virtual intensive outpatient programs (IOP) for substance use disorder (SUD). Brightside Health’s acquisition of Lionrock Recovery launched this new service, enabling the company to provide comprehensive telemental health treatment for a wider range of mental health conditions, including anxiety, depression, suicidal thoughts, alcohol use disorder, and SUD.

MMIT (Managed Markets Insight & Technology) on LinkedIn:

Personalized patient messages, influencer content creation, AI trends, combatting misinformation: these are just some of what’s discussed in Pharmaceutical Executive’s recent roundtable.

Featured are MMIT’s Jay Shah, Senior Solutions Engineer, and Glen Saunders, VP of Product Management and Strategy, at Skipta.

📹 Watch the full conversation: https://ow.ly/PTWf50Rw8h1.

#PharmaMarketing #DigitalHealthTrends #PatientEngagement #Influence

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs